Greenfield Seitz Capital Management, LLC Novartis Ag Transaction History
Greenfield Seitz Capital Management, LLC
- $310 Billion
- Q3 2025
A detailed history of Greenfield Seitz Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Greenfield Seitz Capital Management, LLC holds 35,453 shares of NVS stock, worth $4.66 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
35,453
Previous 43,367
18.25%
Holding current value
$4.66 Million
Previous $5.25 Billion
13.36%
% of portfolio
1.47%
Previous 1.85%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,603Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...